Tiny device could help improve safety, effectiveness of cell therapy for spinal cord injury patients

A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.

New pharma CEOs in the hot seat

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

February 8, 2024

PRECISIS GmbH celebrates Win at the Innovation Award of the Federal State Baden-Württemberg 2023 – Biotech Investments

Issuer: PRECISIS GmbH / Key word(s): Miscellaneous 22.11.2023 / 14:57 CET/CEST The issuer is solely responsible for the content of this announcement. Heidelberg, November 22nd

November 23, 2023

EC approves BeiGene’s Brukinsa combo for follicular lymphoma

Share this article The latest approval for follicular lymphoma treatment marks the fourth indication for Brukinsa in the European Union. Credit: fizkes / Shutterstock.com. The

November 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.